In contrast, only small areas, if any, of degeneration and reactive fibrosis were observed in tumors treated with combined CDK4/6i and fulvestrant, and the vital tumor tissue area was much larger in these tumors (Supplementary Fig. S8D). This evidence concerns the gene CDK4 and neoplasm.